ENDONOVO THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Share-based Payment Arrangement, Expense of $200.97 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-12-29
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2023-09-30 was -$365.53K.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $20.49K, a 94.05% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $20.49K.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2021-03-31 was $20.47K.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2022 was $45.00K.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2020 was $456.52K, a 134.53% increase from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2019 was $194.65K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$365.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $200.97K 10-Q · filed 2023-12-29 | ||
| 2023-06-30 | $566.50K 10-Q · filed 2023-08-21 | |||
| 2022-12-31 | $45.00K 10-K · filed 2023-04-17 | |||
| 2021-09-30 | $20.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $40.98K derived: sum of 2 quarters · filed 2022-11-21 | $61.45K 10-Q · filed 2022-11-21 | $117.86K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $20.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $40.96K 10-Q · filed 2021-08-23 | $97.37K derived: sum of 3 quarters · filed 2022-04-14 | $441.94K derived: sum of 4 quarters · filed 2022-04-14 |
| 2021-03-31 | $20.47K 10-Q · filed 2021-05-24 | $76.88K derived: sum of 2 quarters · filed 2022-04-14 | $421.45K derived: sum of 3 quarters · filed 2022-04-14 | |
| 2020-12-31 | $56.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-14 | $400.98K derived: sum of 2 quarters · filed 2022-04-14 | $456.52K 10-K · filed 2022-04-14 | |
| 2020-09-30 | $344.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $400.11K 10-Q · filed 2021-11-19 | ||
| 2020-06-30 | $55.54K 10-Q · filed 2021-08-23 | |||
| 2019-12-31 | $194.65K 10-K · filed 2021-04-13 |